 |
市場調查報告書
商品編碼
1147464
脂質市場規模、份額和趨勢分析報告：按產品（甘油三酯、磷脂）、階段（臨床、臨床前）、應用、地區、細分市場預測 2022-2030 年Lipid Market Size, Share & Trends Analysis Report By Product (Triglycerides, Phospholipids), By Phase (Clinical, Pre-clinical), By Application, By Region, And Segment Forecasts, 2022 - 2030 |
||||||
脂質市場的成長與趨勢
根據 Grandview Research 的一份新報告，到 2030 年，全球脂質市場預計將達到 128.5 億美元。這種增長主要是由脂質在功能性食品、功能性飲料和膳食補充劑生產中越來越多的利用所推動的，因為它們具有豐富的特性，例如高能量。在人體中，脂質用於保護神經細胞、支持細胞和其他重要功能，為身體提供維生素，並產生睪丸激素、雌激素和皮質醇等激素，預計在全球範圍內會上升。
可電離脂質由於其治療劑的高遞送效率而在製藥行業中得到越來越多的使用和增長。在 COVID-19 期間，它被廣泛用於將 mRNA 轉移到細胞中。上述因素歸因於脂質納米顆粒市場的增長。
亞太地區的人口增長已成為該地區產業穩定增長的關鍵因素。消費品、保健品、食品和飲料等消費量的增加正在增加該地區對化學成分的需求。該地區還是嘉吉、巴斯夫和嘉裡集團等大公司的所在地，這些公司生產大量油脂以滿足當地需求。
中國是世界上人口最多的國家，人口約14.2億。中國的人口增長正在推動該國食品、飲料和營養補充劑的消費。中國消費者越來越多地轉向含有有益健康成分的功能性飲料。由於這些因素，預計未來幾年中國食品和飲料製造業對脂質的需求將會增長。
由於植物和動物等原材料的現成供應，全球用於脂肪酸開發的原材料供應商數量正在增加。大量的原材料供應商加劇了市場競爭，導致原材料價格和可用性的變化。
COVID-19 的傳播對全球脂質市場的增長產生了積極影響。大流行期間的全球健康危機刺激了對營養補充劑和藥品的需求。此外，製藥行業的消費，尤其是 COVID-19 疫苗的配製，在大流行期間增加了需求。
脂質市場報告要點
甘油三酯是增長最快的產品類別，從 2022 年到 2030 年的複合年增長率為 8.9%。這是由於其在食品和飲料行業越來越多地用於生產功能性食品和飲料。
由於人口增長導致食品消費增加，食品和飲料應用是增長最快的部分，從 2022 年到 2030 年的複合年增長率為 8.9%。
亞太地區是增長最快的地區，複合年增長率為 9.2%，因為人口增長推動了中國和印度等國家/地區功能性食品、營養保健品和藥品的消費量增加。
各國政府對植物和動物來源的脂質的生產和消費的監管預計將在不久的將來阻礙市場增長。
隨著俄羅斯和烏克蘭之間地緣政治衝突的持續，石油、能源、天然氣等的成本不斷上升。這種情況導致了脂肪生產原料價格的上漲。
內容
第 1 章調查方法及範圍
- 市場細分和範圍
- 市場定義
- 信息採購
- 購買的數據庫
- GVR 內部數據庫
- 次要信息
- 第三方視角
- 初步調查
- 主要資訊
- 資訊分析
- 數據分析模型
- 市場形成和數據可視化
- 驗證和發布數據
- 調查範圍和假設
第 2 章執行摘要
- 市場展望
- 按細分市場預測
- 競爭考慮
第 3 章市場變量、趨勢和範圍
- 市場系列展望
- 全球脂質市場
- 描繪滲透率和增長前景
- 行業價值鏈分析
- 原材料趨勢
- 製造和技術趨勢
- 銷售渠道分析
- 供需分析
- 供應
- 要求
- 監管框架
- 市場動態
- 市場驅動因素的影響分析
- 日益增長的健康問題增加了全球對膳食補充劑的需求
- 由於其卓越的功能特性，脂質在各種應用中的使用越來越多
- 市場約束影響分析
- 原材料價格波動
- 行業問題
- 市場驅動因素的影響分析
- COVID-19 對行業的影響
- 東歐地緣政治爭端對行業的影響
- 生產成本分析
- 納米脂質在藥物中的潛力
- 商業環境分析
- 波特的分析
- PESTEL 分析
第 4 章脂質市場：產品估計和趨勢分析
- 2021 年和 2030 年產品趨勢分析和市場份額（千噸）（百萬美元）
- 離子脂質（脂質納米顆粒）
- mRNA
- 小干擾RNA
- 其他
- 甘油三酯
- 鞘脂
- 磷脂
- 其他（中性脂質、聚乙二醇化脂質）
- 離子脂質（脂質納米顆粒）
第 5 章脂質市場：階段估計和趨勢分析
- 相變分析和市場份額，2021 年和 2030 年（千噸）（百萬美元）
- 臨床階段
- 臨床前階段
- 其他
第 6 章脂質市場：應用估計和趨勢分析
- 應用變化分析和市場份額，2021 年和 2030 年（千噸）（百萬美元）
- 醫藥
- 疫苗和藥物
- 科學研究
- 營養和補充劑
- 食品和飲料
- 其他
- 醫藥
第 7 章脂質市場：區域估計和趨勢分析
- 2021 年和 2030 年各地區的趨勢分析和市場份額（千噸）（百萬美元）
- 北美
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 德國
- 英國
- 法國
- 西班牙
- 意大利
- 比利時
- 俄羅斯
- 土耳其
- 亞太地區
- 中國
- 印度
- 日本
- 澳大利亞
- 印度尼西亞
- 泰國
- 菲律賓
- 馬來西亞
- 越南
- 韓國
- 拉丁美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 中東和非洲
- 沙特阿拉伯
- 南非
- 阿拉伯聯合酋長國
- 埃及
- 尼日利亞
- 北美
第 8 章脂質市場 - 競爭格局
- 主要市場進入者的近期趨勢和影響分析
- 公司/競爭對手分類（主要創新者、市場領導者、初創企業）
- 供應商情況
- 原材料供應商名單
- 製造商列表
- 主要分銷商和渠道合作夥伴列表
- 潛在最終用戶列表
- 2021 年主要參與者的市場定位分析
- 戰略框架
第 9 章公司簡介
- Evonik Industries AG
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Precision Nanosystems
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Merck Kgaa
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Genevant Sciences
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Exelead
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Avanti Polar Lipids
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Nippon Fine Chemicals Co. Ltd.
- 公司簡介
- 財務業績
- 產品基準
- Lipoid Gmbh
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Cargill, Incorporated
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- BASF SE
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Archer Daniels Midland Company（ADM）
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Koninklijke DSM NV
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Kerry Group Plc
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Nordic Naturals, Inc.
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Clover Corporation
- 公司簡介
- 財務業績
- 產品基準
- Croda International Plc
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Lipoid Kosmetik AG
- 公司簡介
- 財務業績
- 產品基準
- 戰略舉措
- Omega Protein Corporation
- 公司簡介
- 財務業績
- 產品基準
Lipid Market Growth & Trends:
The global lipid market is expected to reach USD 12.85 billion by 2030, as per the new report by Grand View Research, Inc. The growth is majorly driven by the rising utilization of lipids in the production of functional food, functional beverages, and dietary supplements owing to their rich properties such as high in energy. In the human body, lipids are used for protecting nerve cells, supporting cells and other essential functions, supplying vitamins to the body, producing hormones such as testosterone, estrogen, and cortisol, etc., which is expected to propel the demand for lipids over the projected years globally.
Ionizable lipids have been growing due to its increasing use in the pharmaceutical industry due to their high efficiency in delivering therapeutics. During COVID-19, it was widely used for transferring mRNA to cells. These above-mentioned factors are attributed to the growth of the lipid nanoparticle market.
Population growth in the Asia Pacific has been a key factor for the steady pace of growth of industries in the region. Rising consumption of consumer products, healthcare products, food & beverages products, and others has augmented the demand for chemical ingredients in the region. In addition, the region has the presence of major market players, such as Cargill Incorporated, BASF SE, and Kerry Group plc, which have been producing lipids in large volumes to fulfill the requirements in the region.
China is the most populous country in the world with population of approximately 1.42 billion. Rising population of China has propelled the consumption of food & beverages and nutritional supplements in the country. Chinese consumers are more inclined toward functional beverages that contain ingredients beneficial to health. This factor is expected to augment the demand for lipids in the manufacturing of food & beverages in China over the projected years.
The easy availability of sources such as plants and animals has resulted in an increased number of suppliers of raw materials used for developing fatty acids across the world. This high number of raw material suppliers results in intense competition in the market, thereby leading to an inconsistency in prices and availability of raw materials.
The spread of COVID-19 positively impacted the growth of the lipid market across the world. The massive health crisis worldwide during the pandemic fueled the demand for dietary supplements and medicines. Furthermore, its consumption in the pharmaceuticals industry, particularly for the formulation of the COVID-19 vaccines, enhanced its demand during the pandemic.
Lipid Market Report Highlights:
- Triglycerides is the fastest growing product segment with a CAGR of 8.9% from 2022 to 2030 on the account of its rising application in food & beverages industry for the formulation of functional food and functional beverages
- Food & beverages application is the fastest growing segment with a CAGR of 8.9% from 2022 to 2030 owing to the increasing consumption of food on the account of rising population
- Asia Pacific is the fastest growing region with a CAGR of 9.2% because of the increasing consumption in functional food, dietary supplements, and medicines in the countries like China and India owing to the increasing population
- The presence of government regulations related to the production and consumption of lipids in different countries owing to the usage of plants and animals for developing them is anticipated to hinder the growth of the market over the foreseeable future
- The ongoing European geopolitical conflict between Russia and Ukraine has led to a hike in the costs of oil, energy, natural gas, etc. This situation has resulted in the price hike of raw materials for lipid production
Table of Contents
Chapter 1 Methodology And Scope
- 1.1 Market Segmentation & Scope
- 1.2 Market Definition
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Third Party Perspective
- 1.3.5 Primary Research
- 1.3.6 Primary Sources
- 1.4 Information Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Data Visualization
- 1.6 Data Validation & Publishing
- 1.7 Research Scope And Assumptions
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segmental Outlook
- 2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Global Lipid Market
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 Industry Value Chain Analysis
- 3.3.1 Raw Material Trends
- 3.3.2 Manufacturing/Technology Trends
- 3.3.3 Sales Channel Analysis
- 3.4 Supply-Demand Analysis
- 3.4.1 Supply
- 3.4.2 Demand
- 3.5 Regulatory Framework
- 3.6 Price Trend Analysis, 2018 - 2030
- 3.7 Market Dynamics
- 3.7.1 Market Driver Impact Analysis
- 3.7.1.1 Growing Global Demand For Dietary Supplements Owing To Rising Health Concerns
- 3.7.2 Increasing Usage Of Lipids In Various Applications Due To Their Superior Functional Properties
- 3.7.3 Market Restraint Impact Analysis
- 3.7.3.1 Volatile Feedstock Prices
- 3.7.4 Industry Challenges
- 3.7.1 Market Driver Impact Analysis
- 3.8 Impact Of COVID-19 On The Industry
- 3.9 Impact Of Eastern European Geopolitical Conflict On The Industry
- 3.10 Production Cost Analysis
- 3.11 Opportunities Of Nano Lipids In Pharmaceutical
- 3.12 Business Environment Analysis
- 3.12.1 Porter's Analysis
- 3.12.2 PESTEL Analysis
Chapter 4 Lipid Market: Product Estimates & Trend Analysis
- 4.1 Product Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
- 4.1.1 Ionizable Lipids (Lipid Nano Particles)
- 4.1.1.1 mRNA
- 4.1.1.2 siRNA
- 4.1.1.3 Others
- 4.1.2 Triglycerides
- 4.1.3 Sphingolipids
- 4.1.4 Phospholipids
- 4.1.5 Others (Neutral Lipids, Pegylated Lipids)
- 4.1.1 Ionizable Lipids (Lipid Nano Particles)
Chapter 5 Lipid Market: Phase Estimates & Trend Analysis
- 5.1 Phase Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
- 5.1.1 Clinical Phase
- 5.1.2 Pre-Clinical Phase
- 5.1.3 Others
Chapter 6 Lipid Market: Application Estimates & Trend Analysis
- 6.1 Application Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
- 6.1.1 Pharmaceuticals
- 6.1.1.1 Vaccines And Drugs
- 6.1.1.2 Scientific Research
- 6.1.2 Nutrition & Supplements
- 6.1.3 Food & Beverages
- 6.1.4 Others
- 6.1.1 Pharmaceuticals
Chapter 7 Lipid Market: Regional Estimates & Trend Analysis
- 7.1 Regional Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
- 7.1.1 North America
- 7.1.1.1 U.S.
- 7.1.1.2 Canada
- 7.1.1.3 Mexico
- 7.1.2 Europe
- 7.1.2.1 Germany
- 7.1.2.2 UK
- 7.1.2.3 France
- 7.1.2.4 Spain
- 7.1.2.5 Italy
- 7.1.2.6 Belgium
- 7.1.2.7 Russia
- 7.1.2.8 Turkey
- 7.1.3 Asia Pacific
- 7.1.3.1 China
- 7.1.3.2 India
- 7.1.3.3 Japan
- 7.1.3.4 Australia
- 7.1.3.5 Indonesia
- 7.1.3.6 Thailand
- 7.1.3.7 Philippines
- 7.1.3.8 Malaysia
- 7.1.3.9 Vietnam
- 7.1.3.10 South Korea
- 7.1.4 Central & South America
- 7.1.4.1 Brazil
- 7.1.4.2 Argentina
- 7.1.4.3 Colombia
- 7.1.5 Middle East & Africa
- 7.1.5.1 Saudi Arabia
- 7.1.5.2 South Africa
- 7.1.5.3 U.A.E.
- 7.1.5.4 Egypt
- 7.1.5.5 Nigeria
- 7.1.1 North America
Chapter 8 Lipid Market - Competitive Landscape
- 8.1 Recent Developments & Impact Analysis, By Key Market Participants
- 8.2 Company/Competition Categorization (Key Innovators, Market Leaders, And Emerging Players)
- 8.3 Vendor Landscape
- 8.3.1 List Of Raw Material Suppliers
- 8.3.2 List Of Manufacturers
- 8.3.3 List Of Key Distributors And Channel Partners
- 8.3.4 List Of Potential Endusers
- 8.4 Key Company Market Positioning Analysis, 2021
- 8.5 Strategic Framework
Chapter 9 Company Profiles
- 9.1 Evonik Industries AG
- 9.1.1 Company Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Benchmarking
- 9.1.4 Strategic Initiatives
- 9.2 Precision Nanosystems
- 9.2.1 Company Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Benchmarking
- 9.2.4 Strategic Initiatives
- 9.3 Merck Kgaa
- 9.3.1 Company Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Benchmarking
- 9.3.4 Strategic Initiatives
- 9.4 Genevant Sciences
- 9.4.1 Company Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Benchmarking
- 9.4.4 Strategic Initiatives
- 9.5 Exelead
- 9.5.1 Company Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Benchmarking
- 9.5.4 Strategic Initiatives
- 9.6 Avanti Polar Lipids
- 9.6.1 Company Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Benchmarking
- 9.6.4 Strategic Initiatives
- 9.7 Nippon Fine Chemicals Co. Ltd.
- 9.7.1 Company Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Benchmarking
- 9.8 Lipoid Gmbh
- 9.8.1 Company Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Benchmarking
- 9.8.4 Strategic Initiatives
- 9.9 Cargill, Incorporated
- 9.9.1 Company Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Benchmarking
- 9.9.4 Strategic Initiatives
- 9.10 BASF SE
- 9.10.1 Company Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Benchmarking
- 9.10.4 Strategic Initiatives
- 9.11 Archer Daniels Midland Company (ADM)
- 9.11.1 Company Overview
- 9.11.2 Financial Performance
- 9.11.3 Product Benchmarking
- 9.11.4 Strategic Initiatives
- 9.12 Koninklijke DSM N.V.
- 9.12.1 Company Overview
- 9.12.2 Financial Performance
- 9.12.3 Product Benchmarking
- 9.12.4 Strategic Initiatives
- 9.13 Kerry Group Plc
- 9.13.1 Company Overview
- 9.13.2 Financial Performance
- 9.13.3 Product Benchmarking
- 9.13.4 Strategic Initiatives
- 9.14 Nordic Naturals, Inc.
- 9.14.1 Company Overview
- 9.14.2 Financial Performance
- 9.14.3 Product Benchmarking
- 9.14.4 Strategic Initiatives
- 9.15 Clover Corporation
- 9.15.1 Company Overview
- 9.15.2 Financial Performance
- 9.15.3 Product Benchmarking
- 9.16 Croda International Plc
- 9.16.1 Company Overview
- 9.16.2 Financial Performance
- 9.16.3 Product Benchmarking
- 9.16.4 Strategic Initiatives
- 9.17 Lipoid Kosmetik AG
- 9.17.1 Company Overview
- 9.17.2 Financial Performance
- 9.17.3 Product Benchmarking
- 9.17.4 Strategic Initiatives
- 9.18 Omega Protein Corporation
- 9.18.1 Company Overview
- 9.18.2 Financial Performance
- 9.18.3 Product Benchmarking
List of Tables
- Table 1 Key Company/Competition Categorization
- Table 2 List Of Key Raw Material Suppliers
- Table 3 List Of Manufacturers
- Table 4 List Of Key Distributors And Channel Partners
- Table 5 List Of Potential End Users
List of Figures
- Fig. 1 Lipid Market Segmentation
- Fig. 2 Information Procurement
- Fig. 3 Primary Research Pattern
- Fig. 4 Data Analysis Models
- Fig. 5 Market Formulation And Validation
- Fig. 6 Data Validating & Publishing
- Fig. 7 Market Snapshot, 2021
- Fig. 8 Structural Adhesives Market, Segmental Outlook, 2021 (USD Million)
- Fig. 9 Global Lipid Market Volume & Revenue, 2018 - 2030 (Kilotons) (USD Million)
- Fig. 10 Global Lipid Market Value Chain Analysis
- Fig. 11 Lipid Market Dynamics
- Fig. 12 Market Driver Analysis
- Fig. 13 Global Dietary Supplements Market, 2017 - 2021 (USD Million)
- Fig. 14 Market Restraint Analysis
- Fig. 15 Lipid Market: Porter's Analysis
- Fig. 16 Lipid Market: PESTEL Analysis
- Fig. 17 Lipid Market Revenue Share, By Product, 2021 & 2030 (%)
- Fig. 18 Lipid Market Revenue Share, By Phase, 2021 & 2030 (%)
- Fig. 19 Lipid Market Revenue Share, By Application, 2021 & 2030 (%)
- Fig. 20 Lipid Market Revenue Share, By Region, 2021 & 2030 (%)
- Fig. 21 Mexico Pharmaceuticals Market Size , 2016 - 2021 (in USD Million)
- Fig. 22 Lipid Market: Positioning Analysiss
- Fig. 23 Strategic Framework
